TRC

ESSKA Orthobiologic Initiative (ORBIT): ...
0 comment
In recent years, there has been a growing interest in biologic approaches for tissue healing in various musculoskeletal (MSK) conditions and pathologies, resulting in the emergence of the field of Orthobiologics. This interest has been reflected in the significant surge in research in the MSK medicine field, with numerous pre-clinical studies demonstrating promising evidence from a considerable number of basic science pre-clinical studies, which also translated to promising results in clinical studies.Orthobiologics offer diverse non-operative solutions and can also be used in conjunction with surgical approaches. Platelet Rich Plasma (PRP) products and cell-based therapies (also known as “stem cell therapy”) have been the primary biologic products that have garnered the most attention.The increasing demand from patients to explore non-surgical options before resorting to invasive treatments, coupled with the industry’s investment in accommodating these needs, has heightened interest in orthobiologics. Orthobiologic products have shown potential in regenerating damaged cells and tissues, as well as regulating degenerative processes, and have been effective in improving function and reducing pain in various musculoskeletal (MSK) conditions. This has led to a surge in the use of orthobiologic treatments worldwide that appears to be continuously growing.However, the clinical use of biologic therapies has exceeded the available evidence and supportive research, leading to a surplus of information and misinformation. Some clinicians lack sufficient education, experience, and training in this field, with much of the available information provided by the industry. That is why here at The Regenerative Clinic, we only work with those consultants responsible for teaching other clinicians around the world. We stick with the bests.The ESSKA Orthobologics Initiative (ORBIT) initiative aims to investigate the detailed mechanisms of action of different orthobiologics in pre-clinical models to determine their potential disease-modifying effects. By conducting systematic reviews on the various available orthobiologic products in OA, the initiative’s first study analysed the disease-modifying effects of PRP for knee OA. This review included 44 studies involving over 1200 animals, which showed that PRP injections had clinical effects in 80% of the studies and disease-modifying effects in 68% of the studies. Here at The Regenerative Clinic, our patient success rate is 86% based on data pulled from over 3,000 patients. Full Article If you or someone you know is experiencing joint pain, we can help!We offer a range of orthobiolocigal treatments that use a person’s own harvested cells.Treatments include:MFAT – Micro-fragmented fat – Adipose Tissue therapy and treatment: a pioneering new treatment for pain and inflammation is a new minimally invasive treatment that harnesses natural repair cells removed from your own body fat to target problems affecting the tendons, ligaments, joints and muscles, including osteoarthritis.BMAC – Bone Marrow Aspirate Concentrate (BMAC) is a non-surgical, minimally invasive, regenerative treatment that harnesses the natural ability to heal the body through the assistance of biological growth factors. BMAC utilises the regenerative mesenchymal stem cells collected from bone marrow to aid in the acceleration of healing moderate to severe osteoarthritis and tendon injuries.PRP – Platelet Rich Plasma (PRP) therapy is also known as Autologous Conditioned Plasma. PRP takes advantage of your blood’s natural healing properties to repair damaged cartilage, tendons, ligaments, muscle and bone. It can reduce pain, improve joint function and help you return quickly to normal activities.nSTRIDE – The treatment is designed to be a single injection therapy in the outpatient clinic setting. Blood is withdrawn like a simple blood test, the clinician processes the patient’s blood to concentrate white blood cells, platelets, and plasma proteins into a small volume of plasma. Make an Enquiry
New Tenex Procedure Helps Solve Chronic ...
0 comment
Many people suffer from chronic tendon pain that affects daily activities, often caused by continued trauma or over usage of joints and muscles. The Regenerative Clinic is now offering the Tenex procedure, a minimally invasive non-surgical procedure that helps those who are suffering from chronic tendon pain by non-surgically removing damaged scar tissue and calcifications in the tendons to help restore mobility and circulation to the tendon site, as well as encouraging regrowth of healthy tissue. This procedure, developed by Tenex Health in collaboration with a world-renowned US Clinic, is particularly effective on the tendons of the elbow, shoulder, knees, and ankle. This procedure is a good option for patients who have been struggling with chronic tendon pain and are looking for an alternative to steroid injections, physiotherapy, traditional tendon repair surgery, or where the traditional methods have failed to produce results. It can treat tendon and soft-tissue injuries, including rotator cuff tendonitis, Achilles tendonitis, patellar tendonitis (jumper’s knee), plantar fasciitis and both lateral and medial epicondylitis (tennis elbow or golfers elbow).For more information on the Tenex procedure, see our Tenex page. How it works:Before the procedure, ultrasound imaging is used to visualize the affected area and to get a continuous view of the damaged tendon as they work. When this is done, they’ll make a tiny incision and insert a probe into the incision. The needle-like tip of this probe vibrates very rapidly, producing ultrasonic energy. This energy causes the damaged tissue to break down, while healthy tissue remains intact. As damaged tissue breaks down, a system within the probe works to remove it from your body. The procedure takes less than 30 minutes to complete and recovery can be as quick as 4-6 weeks. Make an Enquiry
Study Finds 26% Of Knee Replacements Are...
0 comment
  Examining Timeliness of Total Knee Replacement Among Patients with Knee Osteoarthritis in the U.S.: Results from the OAI and MOST Longitudinal CohortsH M K Ghomrawi, A I Mushlin, R Kang, S Banerjee, J A Singh, L Sharma, C Flink, M Nevitt, T Neogi, D L Riddle. J Bone Joint Surg Am. 2020 Mar 18;102(6):468-476. doi: 10.2106/JBJS.19.00432. In this Meta-analysis of two large multicenter cohort studies, 3,417 knees from 2313 patients with osteoarthritis (OA) were divided using a sixteen combination algorithm (including WOMAC pain and physical function, and Kellgren Lawrence grading) to determine their ‘appropriateness’ to undergo surgical intervention with total knee arthroplasty (TKA). They were followed up for a total of 8 years. The main aim was to identify the timeliness of surgical procedures and determine if the appropriate standards of patient healthcare are being met. The results showed that of 1,114 knee replacements carried out in the two-year study period, 26.4% were considered in this classification as ‘premature’ that is, that they were carried out on individuals where alternative/biological intervention would have been more suitable. Of the 3,123 knees classified as appropriate for TKA, 2,833 were NOT replaced (90%). Although this study may not be representative of treatment in every location, there is no National longitudinal data available for comparison, so this remains the most accurate estimation for statistical evaluation. This data indicates that currently, patients may not be receiving the appropriate advice and highest level of personalized healthcare in the field of orthopedics.    Professor Mark Slevin PhD2, FRCPath, FAHAScientific Director of CCAMF – [Centru Avansat de Cercetari Medicale si Farmaceutice] Universitatea de Medicina, Farmacie, Stiinte se Technologie; “George Emil Palade” din Targu-Mures, Romania and Professor of Cell Pathology- Manchester Metropolitan University
Continuing Professional Development cour...
0 comment
The Regenerative Clinic in conjunction with Living Room Health pride ourselves on our immediate access to specialist consultants, and on-site diagnostic modalities including MRI and Ultrasound – and top radiology sub-specialist consultants to interpret and report.Our suite of governance and multi-disciplinary medical professionals keep us up to date on our rapidly adapting healthcare system. This is why we’ve decided to launch ‘Living Room Learn’ – a bespoke range of CPD courses aimed to provide courses delivered by professionals and experts in their field.We offer both virtual and face-to-face events with access to live tutorials too. What courses do we offer?We endeavour to provide a range of courses to enable you opportunities to both learn and network across your speciality.We hold monthly courses ranging from 1-2 hours in duration. We also have quarterly masterclasses which can provide up to 5 CPD points. Tell us what you think. – we also welcome your ideas on new topics for future Living Room Learn. Our speakersOur speakers are invested in our business and range from General Practitioners to Professors and Consultants, specialist physiotherapists and radiologists.Our speakers are experts in their field and have been hand-picked by our Medical Advisory Committee to not only present and teach but also consult and practice with us. The content of each course is carefully considered by experts in the field and scrutinised to ensure that you are receiving up-to-date information on the latest techniques, diagnoses, and treatments. Our pricesOur courses are just £15+VAT for the rest of 2022 CoursesOur first course kicks off on Thursday 29 September and is titled BIOLOGICS: JOINT PAIN AND NON-SURGICAL INTERVENTIONS. Please click here for more information. Book Here

Get in touch

Get in touch

Find your clinic

We offer appointments nationwide and now working with partners abroad providing cutting edge Regenerative Medicine to patients in Dubai, Australia, Spain and Pakistan.